Hisamitsu Pharmaceutical HTSUF Stock
Hisamitsu Pharmaceutical Price Chart
Hisamitsu Pharmaceutical HTSUF Financial and Trading Overview
| Hisamitsu Pharmaceutical stock price | 32.3 USD |
| Previous Close | 28.78 USD |
| Open | 28.78 USD |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | 28.78 - 28.78 USD |
| 52 Week Range | 23.36 - 30.78 USD |
| Volume | 5 USD |
| Avg. Volume | 3 USD |
| Market Cap | 2.25B USD |
| Beta (5Y Monthly) | 0.557088 |
| PE Ratio (TTM) | 27.150946 |
| EPS (TTM) | 2.06 USD |
| Forward Dividend & Yield | 0.64 (2.20%) |
| Ex-Dividend Date | August 30, 2023 |
| 1y Target Est | N/A |
HTSUF Valuation Measures
| Enterprise Value | -130293514240 USD |
| Trailing P/E | 27.150946 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.01751566 |
| Price/Book (mrq) | 0.008727755 |
| Enterprise Value/Revenue | -1.015 |
| Enterprise Value/EBITDA | -7.871 |
Trading Information
Hisamitsu Pharmaceutical Stock Price History
| Beta (5Y Monthly) | 0.557088 |
| 52-Week Change | 6.51% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 30.78 USD |
| 52 Week Low | 23.36 USD |
| 50-Day Moving Average | 28.78 USD |
| 200-Day Moving Average | 26.5 USD |
HTSUF Share Statistics
| Avg. Volume (3 month) | 3 USD |
| Avg. Daily Volume (10-Days) | 0 USD |
| Shares Outstanding | 78.1M |
| Float | 57.07M |
| Short Ratio | N/A |
| % Held by Insiders | 26.45% |
| % Held by Institutions | 35.41% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 84 |
| Trailing Annual Dividend Yield | 291.86% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0.568 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | February 28, 2023 |
| Most Recent Quarter (mrq) | February 28, 2023 |
| Next Fiscal Year End | February 28, 2024 |
Profitability
| Profit Margin | 9.15% |
| Operating Margin (ttm) | 9.03% |
| Gross Margin | 56.65% |
| EBITDA Margin | 12.89% |
Management Effectiveness
| Return on Assets (ttm) | 2.35% |
| Return on Equity (ttm) | 4.72% |
Income Statement
| Revenue (ttm) | 128.33B USD |
| Revenue Per Share (ttm) | 1617.47 USD |
| Quarterly Revenue Growth (yoy) | 8.69% |
| Gross Profit (ttm) | N/A |
| EBITDA | 16.55B USD |
| Net Income Avi to Common (ttm) | 11.74B USD |
| Diluted EPS (ttm) | 1.06 |
| Quarterly Earnings Growth (yoy) | -35.50% |
Balance Sheet
| Total Cash (mrq) | 136.87B USD |
| Total Cash Per Share (mrq) | 1760.49 USD |
| Total Debt (mrq) | 2.3B USD |
| Total Debt/Equity (mrq) | 0.89 USD |
| Current Ratio (mrq) | 4.678 |
| Book Value Per Share (mrq) | 3297.526 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 12.73B USD |
| Levered Free Cash Flow (ttm) | 10.12B USD |
Profile of Hisamitsu Pharmaceutical
| Country | United States |
| State | N/A |
| City | Tosu |
| Address | 408, Tashiro Daikan-machi |
| ZIP | 841-0017 |
| Phone | 81 3 5293 1720 |
| Website | https://www.hisamitsu.co.jp |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 2769 |
Hisamitsu Pharmaceutical Co., Inc. manufactures and sells pharmaceuticals, quasi-drugs, and medical devices in Japan. The company provides external pain relieving drugs under the SALONPAS, NOBINOBI, SALONSIP, AIR, SALONPAS, and FEITAS; and BUTENALOCK, a remedy for athlete's foot, as well as ALLEGRA FX, a sinus medication for allergies. It also manufactures and sells quasi-drugs and cosmetics; MOHRUS TAPE and MOHRUS PAP XR, transdermal analgesic anti-inflammatory drug; patches for female hormone, asthma treatment, and treatment for overactive bladders. In addition, the company manufactures and sells drugs under MOHRUS TAPE, MOHRUS PAP XR, FENTOS Tapes, NEOXY Tapes, Abstral, ALLESAGA Tapes, HARUROPI Tapes, and MENOAID Combipatch. Further, it provides HFT-290, a transdermal patch for cancer pain. The company sells its products in the United States and Asia. Hisamitsu Pharmaceutical Co., Inc. was founded in 1847 and is headquartered in Tosu, Japan.
Q&A For Hisamitsu Pharmaceutical Stock
What is a current HTSUF stock price?
Hisamitsu Pharmaceutical HTSUF stock price today per share is 32.3 USD.
How to purchase Hisamitsu Pharmaceutical stock?
You can buy HTSUF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Hisamitsu Pharmaceutical?
The stock symbol or ticker of Hisamitsu Pharmaceutical is HTSUF.
Which industry does the Hisamitsu Pharmaceutical company belong to?
The Hisamitsu Pharmaceutical industry is Drug Manufacturers-Specialty & Generic.
How many shares does Hisamitsu Pharmaceutical have in circulation?
The max supply of Hisamitsu Pharmaceutical shares is 72.93M.
What is Hisamitsu Pharmaceutical Price to Earnings Ratio (PE Ratio)?
Hisamitsu Pharmaceutical PE Ratio is 15.67961200 now.
What was Hisamitsu Pharmaceutical earnings per share over the trailing 12 months (TTM)?
Hisamitsu Pharmaceutical EPS is 2.06 USD over the trailing 12 months.
Which sector does the Hisamitsu Pharmaceutical company belong to?
The Hisamitsu Pharmaceutical sector is Healthcare.